425: Rezolve AI Criticizes Commerce.com Board Amid Acquisition Proposal

Rezolve AI plc has publicly criticized Commerce.com, Inc.'s board for rejecting a takeover proposal and adopting a poison pill, citing significant value destruction and poor financial performance.

Summary

• Rezolve AI plc is making a proposal for a business combination with Commerce.com, Inc.
• Commerce.com's value has declined 96% from its post-IPO peak.
• Commerce.com has experienced anemic revenue growth of 3%, with only 1.5% forecast for 2026.
• Net revenue retention at Commerce.com is below the company's targets.
• Commerce.com's stock has limited liquidity, potentially making it difficult for shareholders to exit without impacting the price.
• Rezolve AI argues Commerce.com lacks an architecture for the era of agentic commerce.
• A fully funded acquirer made a credible proposal which the Commerce.com Board rejected.
• The Commerce.com Board adopted a 'poison pill' defense, preventing shareholders from deciding on the proposal.
• Rezolve AI believes the Commerce.com Board is squandering the company's real assets.
• AI-driven e-commerce is projected to reach $144 billion by 2029.
• Rezolve AI aims to create a hyper-scaler to help retailers capitalize on agentic commerce.
• The combined entity would have 60,000 storefronts, Brain Suite, RezolvePay, and a commerce-specific AI model.
• The combined business is projected to have over $700 million in revenue with core software margins exceeding 90%.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as highly negative due to the severe criticism of Commerce.com's management, its drastically declining value, poor financial performance, and the board's defensive actions against a potential acquisition.

Positives

• Rezolve AI's proposed combination could create a significant player in AI-driven e-commerce.
• The combined entity is projected to have substantial revenue ($700 million+) and high software margins (>90%).
• Rezolve AI highlights the significant growth potential of AI-driven e-commerce, with a market forecast of $144 billion by 2029.
• Rezolve AI possesses a commerce-specific AI model ('brainpowa') that improves with each sale.
• Commerce.com has real assets that could be leveraged.
• A credible acquisition proposal was made by a fully funded acquirer.

Negatives

• Commerce.com's stock value has plummeted 96% from its post-IPO peak.
• Commerce.com exhibits anemic revenue growth of only 3%, with a low forecast of 1.5% for 2026.
• Commerce.com's net revenue retention is below its own targets.
• Commerce.com's stock has very limited liquidity, posing exit challenges for shareholders.
• Commerce.com's Board rejected a credible acquisition proposal and implemented a 'poison pill' defense.
• Rezolve AI alleges the Commerce.com Board is mismanaging company assets.
• There is a perceived lack of progress and a recurring '12 months away' timeline for future developments at Commerce.com.

Risks

• The ultimate outcome of the proposed transaction between Rezolve AI and Commerce.com is uncertain.
• Commerce.com may not cooperate with Rezolve AI regarding the proposed transaction.
• Rezolve AI may be unable to complete the transaction with Commerce.com.
• Required shareholder and regulatory approvals for the transaction may not be obtained.
• Expected synergies and operating efficiencies from the integration may not be achieved within expected timeframes or at all.
• The integration of Commerce.com's operations may be more difficult, time-consuming, or costly than anticipated.
• Operating costs, customer loss, and business disruption could be greater than expected post-transaction.
• Competition in the AI and e-commerce sectors poses a risk to growth and profitability.
• Changes in applicable laws or regulations could impact operations.
• Economic weakness, market trends, and general market uncertainty could affect performance.
• Inflation or rising interest rates could negatively impact Rezolve AI's business.

Future Outlook

Rezolve AI anticipates creating a hyper-scaler to capitalize on the agentic commerce opportunity, combining 60,000 storefronts with its AI technologies to achieve over $700 million in combined revenue and more than 90% core software margins. The company questions Commerce.com's Board on their timeline to deliver similar results.

Management Comments

• Commerce. GONE 96% that is how much value commerce.com has lost since its post-IPO peak
• Anemic revenue growth of 3%, with just 1.5% forecast in 2026
• Net revenue retention which is below the company's own targets
• A stock with such limited liquidity that shareholders could have trouble exiting without moving the price against themselves
• No architecture for the era of agentic commerce
• A fully funded acquirer made a credible proposal. The Board rejected it and then adopted a poison pill to prevent shareholders from deciding for themselves.
• Commerce.com has real assets. The Board is squandering them.
• Demand to know why.
• Where is the VALUE?
• Why is the "future" always 12 months away?
• Ask your Board one question What is your timeline to deliver such results?
• Stop waiting for the roadmap Start investing in the reality

Industry Context

StockSavvy.ai notes that Rezolve AI's aggressive stance against Commerce.com's board highlights a critical juncture in the e-commerce sector, where AI integration and agentic commerce are rapidly becoming dominant trends. The projected $144 billion market for AI-driven e-commerce by 2029 underscores the urgency for companies to adapt, and Rezolve AI appears to be positioning itself as a leader in this transformation, contrasting sharply with Commerce.com's perceived stagnation.

Comparison to Industry Standards

• Commerce.com's revenue growth of 3% and a 1.5% forecast for 2026 significantly underperforms the rapidly expanding AI-driven e-commerce market, which is projected to reach $144 billion by 2029.
• Rezolve AI's projected combined revenue of over $700 million with >90% core software margins sets a high benchmark, contrasting with Commerce.com's current anemic growth and below-target net revenue retention.
• The adoption of a 'poison pill' by Commerce.com's board is a defensive tactic often seen when a company faces perceived undervaluation or unsolicited takeover bids, a situation Rezolve AI is actively exploiting by highlighting Commerce.com's poor performance relative to market potential.

Corporate Governance

Stakeholder Impact

• Shareholders of Commerce.com: May be unable to realize value from a potential acquisition due to the board's rejection of a proposal and adoption of a poison pill. Limited liquidity also poses exit challenges.
• Shareholders of Rezolve AI: Potential for significant upside if the proposed combination is successful and leverages AI-driven e-commerce growth, but also faces integration and market risks.
• Employees of Commerce.com: Uncertainty regarding future employment and company direction given the board's actions and Rezolve AI's critique.
• Customers of Commerce.com: Potential disruption or benefit depending on the outcome of the proposed transaction and integration.

Next Steps

• Rezolve AI may file registration statements, proxy statements, tender offer statements, or other documents with the SEC in furtherance of its proposal.
• Investors and security holders are urged to read any future filings carefully regarding the proposed transaction.
• Rezolve AI may seek shareholder approval for the proposed transaction.

Key Dates

Recommendation

This filing is primarily a commentary from Rezolve AI regarding Commerce.com and its proposed acquisition. While it highlights significant issues with Commerce.com's performance and governance, it does not contain direct financial results or guidance for Rezolve AI itself that would warrant a strong buy or sell. For Commerce.com, the situation is dire, but the outcome of the proposed transaction remains uncertain. Therefore, a 'hold' is appropriate pending further developments or direct filings from Commerce.com.

Keywords

Rezolve AI, Commerce.com, Acquisition, Business Combination, AI, E-commerce, Agentic Commerce, Financial Performance, Shareholder Value, Poison Pill, SEC Filing, 425 Filing